Search Results 1081-1090 of 17243 for Efficacy

  1. Revisiting the measles: Who should get a vaccine? - Mayo Clinic News Network

    Mayo Clinic stands behind the evidence supporting the efficacy and safety of vaccines approved by the Food and Drug Administration and the vaccination schedules ...

  2. Ublituximab-xiiy (intravenous route) - Side effects & uses - Mayo Clinic

    Safety and efficacy have not been established. Geriatric. Appropriate studies performed to date have not demonstrated geriatric-specific problems that would ...

  3. Emricasan, A Caspase Inhibitor, For Treatment Of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

    This is a multicenter, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of emricasan in improving event-free survival ...

  4. A Study Of AAVB-039 In Participants With Stargardt Disease (STGD1) - Mayo Clinic

    The study will also assess initial efficacy following AAVB-039 administration. Participation eligibility. Participant eligibility includes age, gender, type ...

  5. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

    About this study. The purpose of this multicenter, double-blind, randomized, placebo-controlled study is to evaluate the safety and efficacy of emricasan in ...

  6. Coronavirus Disease 2019 (COVID-19) Clinical Trials - Mayo Clinic Research

    This is a phase 3, multi-center, randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of colchicine in adult ...

  7. Esophagitis Clinical Trials - Mayo Clinic Research

    If CYP2C19 genotype can predict the efficacy of healing erosive esophagitis and gastric acid secretion in patients taking once a day omeprazole. Biologic ...

  8. Microbiota Restoration Therapy For Recurrent Clostridium Difficile Infection - Mayo Clinic

    This study will evaluate additional efficacy and safety information about RBX2660 for the treatment of recurrent Clostridium difficile infection (CDI).

  9. Science Saturday: Arresting melanoma's molecular drivers - Mayo Clinic News Network

    "Therapies that turn off the mutated BRAF molecule — cutting the growth signal for cancer — have significant efficacy in people whose melanoma harbors the BRAF ...

  10. Nivolumab (intravenous route) - Side effects & uses - Mayo Clinic

    Safety and efficacy have not been established in children younger than 12 years of age to treat colon and rectal cancer and melanoma or in children to treat ...